Delayed Intensification (DI)

Delayed Intensification (DI) is the fourth phase of treatment for leukemia, following Interim Maintenance, and typically lasts eight weeks of outpatient treatment. The exact treatment varies according to risk level, patient health and the protocol being followed, but it typically involves intense chemotherapy intended to increase the odds of the patient remaining in remission.

The most common drugs given during DI include vincristine, ARA-C, cyclophosphamide, PEG or Erwinia, doxorubicin, dexamethasone, methotrexate, and thioguanine.

Leave a Reply

Your email address will not be published. Required fields are marked *